BIOMAT Database Logo BIOMAT Database Logo

Insulin, C-peptide, glucagon, and somatostatin secretion in segmental pancreatic autotransplantation. 1984

F Fallucca, and R Tersigni, and L Giangrande, and P del Balzo, and D Zicari, and M Marinelli, and G Pimpinella, and G Ghirlanda, and S Stipa

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D011829 Radiation Dosage The amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv). Sievert Units,Dosage, Radiation,Gray Units,Gy Radiation,Sv Radiation Dose Equivalent,Dosages, Radiation,Radiation Dosages,Units, Gray,Units, Sievert
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D002285 Carcinoma, Intraductal, Noninfiltrating A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma. Carcinoma, Intraductal,DCIS,Ductal Carcinoma In Situ,Atypical Ductal Hyperplasia,Intraductal Carcinoma, Noninfiltrating,Atypical Ductal Hyperplasias,Carcinoma, Noninfiltrating Intraductal,Carcinomas, Intraductal,Carcinomas, Noninfiltrating Intraductal,Ductal Hyperplasia, Atypical,Ductal Hyperplasias, Atypical,Hyperplasia, Atypical Ductal,Hyperplasias, Atypical Ductal,Intraductal Carcinoma,Intraductal Carcinomas,Intraductal Carcinomas, Noninfiltrating,Noninfiltrating Intraductal Carcinoma,Noninfiltrating Intraductal Carcinomas
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor

Related Publications

F Fallucca, and R Tersigni, and L Giangrande, and P del Balzo, and D Zicari, and M Marinelli, and G Pimpinella, and G Ghirlanda, and S Stipa
Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine.
January 1979, Diabetes,
F Fallucca, and R Tersigni, and L Giangrande, and P del Balzo, and D Zicari, and M Marinelli, and G Pimpinella, and G Ghirlanda, and S Stipa
Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets.
January 2021, Diabetologia,
F Fallucca, and R Tersigni, and L Giangrande, and P del Balzo, and D Zicari, and M Marinelli, and G Pimpinella, and G Ghirlanda, and S Stipa
Insulin regulates glucagon-like peptide-1 secretion by pancreatic alpha cells.
November 2018, Endocrine,
F Fallucca, and R Tersigni, and L Giangrande, and P del Balzo, and D Zicari, and M Marinelli, and G Pimpinella, and G Ghirlanda, and S Stipa
Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues.
January 2007, Regulatory peptides,
F Fallucca, and R Tersigni, and L Giangrande, and P del Balzo, and D Zicari, and M Marinelli, and G Pimpinella, and G Ghirlanda, and S Stipa
Inhibitory effect of somatostatin-28 on pancreatic polypeptide, glucagon and insulin secretion in normal man.
August 1983, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
F Fallucca, and R Tersigni, and L Giangrande, and P del Balzo, and D Zicari, and M Marinelli, and G Pimpinella, and G Ghirlanda, and S Stipa
Effect of glucagon and somatostatin on pancreatic secretion in dogs.
January 1996, Acta physiologica Hungarica,
F Fallucca, and R Tersigni, and L Giangrande, and P del Balzo, and D Zicari, and M Marinelli, and G Pimpinella, and G Ghirlanda, and S Stipa
Reversal of somatostatin inhibition of insulin and glucagon secretion.
November 1976, Diabetes,
F Fallucca, and R Tersigni, and L Giangrande, and P del Balzo, and D Zicari, and M Marinelli, and G Pimpinella, and G Ghirlanda, and S Stipa
Regulation of pancreatic insulin and glucagon secretion.
January 1976, Annual review of physiology,
F Fallucca, and R Tersigni, and L Giangrande, and P del Balzo, and D Zicari, and M Marinelli, and G Pimpinella, and G Ghirlanda, and S Stipa
[Physiological significance of endogenous somatostatin in insulin and glucagon secretion].
June 1978, Horumon to rinsho. Clinical endocrinology,
F Fallucca, and R Tersigni, and L Giangrande, and P del Balzo, and D Zicari, and M Marinelli, and G Pimpinella, and G Ghirlanda, and S Stipa
Insulin, glucagon, and somatostatin secretion in the regulation of metabolism.
January 1978, Annual review of physiology,
Copied contents to your clipboard!